JPRN-UMIN000006084已完成2 期
A feasibility study of Nab-Paclitaxel followed by Anthracycline-based regimen as adjuvant chemotherapy for breast cancer.(SBCCSG-21) - A feasibility study of Nab-Paclitaxel followed by Anthracycline-based regimen as adjuvant chemotherapy for breast cancer.(SBCCSG-21)
Saitama Breast Cancer Clinical Study Group(SBCCSG)0 个研究点目标入组 30 人开始时间: 2011年8月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 70years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1) HER2 is positive by surgical specimen. 2) Pregnant or lactation women. 3) History of other malignancies within the last 5 years. 4) History of bilateral breast cancer 5) History of serious allergy 6) Patients judged by the investigator to be unfit to be enrolled into the study.
研究者
相似试验
招募中
不适用
Observational study of Nab-paclitaxel followed by Anthracycline based regimen as preoperative chemotherapy for ER-negative resectable primary breast cancerBreast cancerJPRN-UMIN000020994SHINKO HOSPITA40
招募中
不适用
Feasibility study of adjuvant nab-paclitaxel in breast cancerbreast cancerJPRN-UMIN000007725Graduate school of medicine,Chiba University55
已完成
2 期
The safety and efficacy trial of nab-paclitaxel and trastuzumab as neoadjuvant chemotherapy for HER2-positive breast cancerHER2-positive breast cancerJPRN-UMIN000012798Tokyo Medical University Ibaraki Medical Center35
已完成
2 期
PhaseII study of Nab-paclitaxel followed by EC as neoadjuvant chemotherapy for the operable breast cancerBreast cancerJPRN-UMIN000022931Rakuwakai Otowa Hospital Breast oncology department24
已完成
不适用
A phase II study of nab-paclitaxel for pretreated non-small cell lung canceron-small cell lung cancerJPRN-UMIN000012972Kanagawa Cancer Center30